Comment
doi: 10.1001/jamaoncol.2017.0107.
Overestimating the Benefit of Cancer Drugs
Affiliations
- PMID: 28715568
- DOI: 10.1001/jamaoncol.2017.0107
Item in Clipboard
Comment
Overestimating the Benefit of Cancer Drugs
JAMA Oncol.
.
Erratum in
-
Missing Conflict of Interest Disclosure.JAMA Oncol. 2018 Oct 1;4(10):1439. doi: 10.1001/jamaoncol.2018.4091. JAMA Oncol. 2018. PMID: 30128482 Free PMC article. No abstract available.
No abstract available
Comment in
-
Overestimating the Benefit of Cancer Drugs-Reply.JAMA Oncol. 2017 Dec 1;3(12):1738-1739. doi: 10.1001/jamaoncol.2017.1976. JAMA Oncol. 2017. PMID: 28715557 No abstract available.
-
Inconsistent Reporting of Potential Conflicts of Interest.JAMA Oncol. 2018 Oct 1;4(10):1439. doi: 10.1001/jamaoncol.2018.3461. JAMA Oncol. 2018. PMID: 30128488 No abstract available.
Comment on
-
Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines.JAMA Oncol. 2017 Mar 1;3(3):382-390. doi: 10.1001/jamaoncol.2016.4166. JAMA Oncol. 2017. PMID: 28033447
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
